- JP-listed companies
- Income statement
【JP:529A】Income statement
Market cap
P/E ratio
Lecmed develops pharmaceuticals for rare diseases and unmet medical needs, selling treatments to hospitals and pharmacies while retaining full ownership through development to maximize profits.